57 Artículos relativos a Etoglucido

• Protective hypothermia for cancer chemotherapy.
  Publicado en Br J Anaesth
• Epodyl (AY 62013) in advanced cancer involving the brain and other organs.
  Publicado en Cancer
• A technique for intra-arterial infusion of the pelvis.
  Publicado en Aust N Z J Obstet Gynaecol
• The use of hypothermia in intra-arterial chemotherapy for head and neck cancer.
  Publicado en J Laryngol Otol
• Epodyl in the management of cerebral glioma.
  Publicado en Neurology
• Hypothermia and cancer chemotherapy.
  Publicado en Anesth Analg
• Metabolism of triethyleneglycol-bis-2,3 epoxy propyl ether (Epodyl) in the rat.
  Publicado en Xenobiotica
• Chemotherapy of vesical and prostatic tumours.
  Publicado en Br J Urol
• Alkylierende cytostatica.
  Publicado en Internist (Berl)
• The management of superficial bladder tumours with intravesical Epodyl.
  Publicado en Br J Urol
• Chemotherapy for bladder cancer.
  Publicado en Urology
• Triethylene glycol diglycidyl ether.
  Publicado en IARC Monogr Eval Carcinog Risk Chem Man
• Epodyl-behandling av blaeretumores.
  Publicado en Tidsskr Nor Laegeforen
• Virtsarakon kasvainten hoito.
  Publicado en Duodecim
• Intravesical epodyl in the management of bladder tumors: combined experience of the Yorkshire Urological Cancer Research Group.
  Publicado en J Urol
• Treatment of Condyloma acuminata in male patients.
  Publicado en Eur Urol
• Intravesical and systemic chemotherapy of murine bladder cancer.
  Publicado en Cancer Res
• Epodyl in management of noninvasive vesical neoplasms.
  Publicado en Urology
• The acute effects of various cytotoxic compounds injected into the prostate glands of dogs.
  Publicado en Urol Res
• Epodyl treatment of bladder tumours.
  Publicado en Scand J Urol Nephrol
• Long-term follow-up in patients with superficial bladder tumours treated with intravesical Epodyl.
  Publicado en Br J Urol
• Intracavitary Epodyl for multiple non-invasive, highly differentiated bladder tumours.
  Publicado en Scand J Urol Nephrol
• Inactivation of Epodyl in aluminium foil cups as a cause of ineffective treatment of non-invasive bladder tumours.
  Publicado en Scand J Urol Nephrol
• Chemotherapy of bladder cancer: a review.
  Publicado en Cancer Treat Rep
• Fortschritte in der internistischen behandlung von Harnblasentumoren.
  Publicado en Wien Med Wochenschr
• Prognostic factors influencing survival of patients receiving intravesical epodyl.
  Publicado en J Urol
• Quimioterapia intravesical en tumores superficiales de vejiga.
  Publicado en Arch Esp Urol
• Intravesical chemotherapy of superficial bladder cancer.
  Publicado en Recent Results Cancer Res
• Clinical trials in superficial and invasive bladder cancer.
  Publicado en Turk J Pediatr
• Adjuvant chemotherapy of superficial transitional cell bladder carcinoma: preliminary results of a European organization for research on treatment of cancer. Randomized trial comparing doxorubicin hydrochloride, ethoglucid and transurethral resection alone.
  Publicado en J Urol
• Einfluss pathologischer Urothelveränderungen auf die Resorption von Ethoglucid (Epodyl) aus der Harnblase.
  Publicado en Wien Klin Wochenschr
• The biology and treatment of superficial bladder cancer.
  Publicado en J Clin Oncol
• Intravesical chemotherapy for superficial bladder cancer.
  Publicado en Urology
• Superficial bladder cancer.
  Publicado en Med Pediatr Oncol
• Intravesical chemotherapy--frequency of instillation.
  Publicado en Prog Clin Biol Res
• Adjuvant chemotherapy of superficial transitional cell carcinoma: an E.O.R.T.C. randomized trail comparing doxorubicin hydrochloride, ethoglucid and TUR-alone.
  Publicado en Prog Clin Biol Res
• Therapeutic approaches including interferon to carcinoma in situ of the bladder.
  Publicado en Cancer Treat Rev
• Intravesical ethoglucid (Epodyl) for treatment of noninvasive bladder cancer (stage Ta).
  Publicado en Ups J Med Sci
• Intravesical chemotherapy: in vitro studies on the relationship between dose and cytotoxicity.
  Publicado en Urol Res
• Intravesical chemotherapy. Studies on the relationship between pH and cytotoxicity.
  Publicado en Cancer
• Intravesical chemotherapy: studies on the relationship between osmolality and cytotoxicity.
  Publicado en J Urol
• Superficial bladder cancer: intravesical chemotherapy and tumour progression to muscle invasion or metastases.
  Publicado en Br J Urol
• Intravesical chemotherapy: combination with Tween 80 increases cytotoxicity in vitro.
  Publicado en Urol Res
• Ureteropyeloscopic tumour treatment.
  Publicado en Scand J Urol Nephrol Suppl
• The ultrastructure of transitional cell carcinomas of the human urinary bladder treated with ethoglucid or mitomycin.
  Publicado en J Urol
• Acute abdomen arising as a result of intravesical chemotherapy.
  Publicado en J R Soc Med
• Long-term follow-up in superficial transitional cell carcinoma of the bladder: prognostic factors for time to first recurrence, recurrence rate, and survival. Final results of a randomized trial comparing doxorubicin hydrochloride, ethoglucid, and transurethral resection alone. EORTC Genitourinary Tract Cancer Cooperative Group.
  Publicado en Prog Clin Biol Res
• Kurzzeit- versus Langzeitchemorezidivprophylaxe mit Epodyl nach TUR beim oberflächlichen Harnblasenkarzinom.
  Publicado en Urologe A
• Recurrent superficial transitional cell carcinoma of the bladder: adjuvant topical chemotherapy versus immunotherapy. A prospective randomized trial.
  Publicado en J Urol
• Long-term follow-up of intravesical Epodyl therapy for superficial bladder cancer.
  Publicado en Br J Urol
• Secondary hematologic neoplasm after intravesical chemotherapy for superficial bladder carcinoma.
  Publicado en Cancer
• How effective is topical alpha-2b interferon in preventing recurrence of superficial bladder cancer?.
  Publicado en Br J Urol
• Adjuvant topical chemotherapy versus immunotherapy in primary superficial transitional cell carcinoma of the bladder.
  Publicado en Br J Urol
• Intravesical therapy with adriamycin and 4-epirubicin for superficial bladder cancer: the experience of the EORTC GU Group.
  Publicado en Cancer Chemother Pharmacol
• Complications of intravesical chemotherapy.
  Publicado en Urol Clin North Am
• Prospective, randomized trial to evaluate high-versus low-dose interferon-alpha 2b versus conventional chemotherapy in prevention of the recurrence of superficial transitional cell carcinoma of the urinary bladder.
  Publicado en Anticancer Drugs
• Topische Immuntherapie (KLH) vs. Chemotherapie (Ethoglucid) in der Rezidivprophylaxe oberflächlicher Harnblasenkarzinome. Eine prospektiv randomisierte Studie.
  Publicado en Urologe A